As a generally held principle, mere investment or ownership interest in a company does not expose the investor to liability for acts undertaken by the company. However, that principle is being called into question in the context of private equity firms investing in healthcare companies. In two recent cases, healthcare companies along with their sole or majority private equity firm owners settled False Claims Act (“FCA”) cases. These cases illustrate the risk that private equity investors in the healthcare space may face under the FCA, particularly to the extent that they actively manage their portfolio companies.
Trending
- Iterative Health Closes $77 Million Series C to Accelerate the Future of Clinical Research (Business Wire)
- Private Equity vs. Independent Medicine: When Wall Street Enters the Exam Room (Working Healthcare – the Podcast Fixing Healthcare)
- Artificial Intelligence Is Not the End of the Physician (JAMA)
- Charted: The most (and least) burned out physician specialties (Advisory Board)
- Growth, practice value and mergers: A strategic guide for physicians (Medical Economics)
- The potential ‘litigation wave’ headed for GI (Becker’s GI & Endoscopy)
- Groundbreaking new study shows real-time AI platform better at diagnosing cancer than biopsy (UMass Chan Medical School)
- Investigational endoscopic therapy maintains weight after GLP-1 discontinuation (GI & Hepatology News)
